MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,284K
(11.24%↑ Y/Y)
Interest and other income
$3,052K
(325.07%↑ Y/Y)
Change in fair value of
warrants
-$670K
Clinical treatment
programs - us
$26K
Loss on issuance of
warrants
-$3,977K
Operating loss
-$2,447K
(45.49%↑ Y/Y)
Total revenues
$26K
(-25.71%↓ Y/Y)
Issuance cost
$433K
Interest expense and
other finance costs
$148K
(-26.73%↓ Y/Y)
Gain (loss) on
investments
-$1K
(-100.37%↓ Y/Y)
Total costs and
expenses
$2,473K
(-45.34%↓ Y/Y)
General and
administrative
$1,798K
(-41.60%↓ Y/Y)
Research and development
$607K
(-57.76%↓ Y/Y)
Production costs
$68K
(750.00%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM)